Related Experiment Video

Updated: Aug 15, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Inhibition of oestrogen synthesis in postmenopausal women with breast cancer

V H James1, M J Reed, A Purohit

  • 1Unit of Metabolic Medicine, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, England.

The Journal of Steroid Biochemistry and Molecular Biology
|September 1, 1992
PubMed

Insights

This study investigated aromatase and sulphatase inhibitors for reducing oestrogen exposure in breast cancer patients. Both 4-Hydroxyandrostenedione and Danazol showed potential, highlighting the need for more effective enzyme inhibitors.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Elevated oestrogen levels are a key driver in hormone-dependent breast cancer.
  • Enzyme inhibitors targeting oestrogen synthesis and metabolism are crucial therapeutic strategies.

Purpose of the Study:

  • To evaluate the efficacy of an aromatase inhibitor (4-Hydroxyandrostenedione) and a sulphatase inhibitor (Danazol) in reducing oestrogen exposure in breast cancer patients.
  • To investigate the source of oestrone sulphate in breast tissues.
  • To assess the potential for developing more potent enzyme inhibitors.

Main Methods:

  • In vivo studies in breast cancer patients.
  • Measurement of plasma oestrogen levels.
  • Assessment of aromatase and sulphatase enzyme activity.
  • Analysis of oestrone sulphate levels in breast tissue.

Main Results:

  • 4-Hydroxyandrostenedione reduced plasma oestrogen, inhibited aromatization, and decreased DNA polymerase alpha activity, indicating reduced cellular proliferation.
  • Oestrone sulphate in breast tissue originated from circulating oestrone, not direct plasma conjugate accumulation.
  • Danazol lowered plasma oestrone and inhibited tissue sulphatase activity, though it proved to be a weak sulphatase inhibitor.

Conclusions:

  • Aromatase inhibitors like 4-Hydroxyandrostenedione are effective in reducing oestrogen exposure and cellular proliferation.
  • Danazol's inhibition of sulphatase activity suggests potential, but more potent sulphatase inhibitors are needed.
  • Enzyme inhibition is a validated treatment for breast cancer, emphasizing the importance of developing superior inhibitors.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...